Eloy, J.A.; Barredo-Vacchelli, G.R.; RodrÃguez, J.A.; Richichi, B.; Marradi, M.; Camperi, S.A.
Trivalent Peptide Design for Bevacizumab Salt-Induced Affinity Precipitation. Proceedings 2026, 137, 58.
https://doi.org/10.3390/proceedings2026137058
AMA Style
Eloy JA, Barredo-Vacchelli GR, RodrÃguez JA, Richichi B, Marradi M, Camperi SA.
Trivalent Peptide Design for Bevacizumab Salt-Induced Affinity Precipitation. Proceedings. 2026; 137(1):58.
https://doi.org/10.3390/proceedings2026137058
Chicago/Turabian Style
Eloy, Joaquin A., Gabriela R. Barredo-Vacchelli, Jésica A. RodrÃguez, Barbara Richichi, Marco Marradi, and Silvia A. Camperi.
2026. "Trivalent Peptide Design for Bevacizumab Salt-Induced Affinity Precipitation" Proceedings 137, no. 1: 58.
https://doi.org/10.3390/proceedings2026137058
APA Style
Eloy, J. A., Barredo-Vacchelli, G. R., RodrÃguez, J. A., Richichi, B., Marradi, M., & Camperi, S. A.
(2026). Trivalent Peptide Design for Bevacizumab Salt-Induced Affinity Precipitation. Proceedings, 137(1), 58.
https://doi.org/10.3390/proceedings2026137058